Testing effectiveness (Phase 2)Not Yet RecruitingNCT04176081
What this trial is testing
Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer
Who this might be right for
Prostate Cancer
University Health Network, Toronto 208